2019 American Transplant Congress
Living Kidney Donors Who Lose Weight in Order to Be Able to Donate, Gain More Weight after Donation
*Purpose: Living donor kidney transplantation is widely accepted to be the treatment of choice for end-stage kidney disease, and great efforts are undertaken to expand…2019 American Transplant Congress
Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study
*Purpose: From our CISTEM study of linked national registries, we reported that older recipient age, female sex, diabetic kidney failure, non-standard-criteria organs, and mTORi-based IS…2019 American Transplant Congress
Patient Perspectives of Informed Consent for Deceased Donor Organ Intervention Research
*Purpose: Interventions on deceased donors or their organs hold promise for increasing the quantity and quality of organs for transplantation by minimizing organ injury and…2019 American Transplant Congress
Disparities in Pediatric Liver Transplant Waitlist Access
1Emory University, Atlanta, GA, 2University of Washington, Seattle, WA
*Purpose: While disparities in access to liver transplant are well documented among adults, differences in access to the waitlist for children in remote or underserved…2019 American Transplant Congress
Are We Underestimating The Number Of Paired Kidney Exchange Transplants In The United States? Relationship Insights From The National Kidney Registry
1Epidemiology, UNC Chapel Hill, Chapel Hill, NC, 2Johns Hopkins University, Baltimore, MD
*Purpose: Despite an overall decline in the number of living donor kidney transplants (LDKTs) since 2005, Kidney Paired Donation (KPD) rates have increased over the…2019 American Transplant Congress
LCP-Tacrolimus (LCPT; Envarsus XR) Dosing Considerations in De Novo Kidney Transplant Recipients
*Purpose: Different initial dosing strategies were studied in Phase II/Phase III trials evaluating the pharmacokinetics, safety, and efficacy of LCPT in de novo kidney transplantation.…2019 American Transplant Congress
Opening the Doors of Hope: HIV-Positive Living Kidney Donation
Duke University Medical Center, Durham, NC
*Purpose: Living donation (LD) has been allowed under the HOPE Act since 2013, yet to date there have been no HIV+ LD organ transplants performed…2019 American Transplant Congress
To Each Their Own: Center-Level Variation in Tailoring Induction Immunosuppression to Kidney Transplant Recipients
Johns Hopkins University, Baltimore, MD
*Purpose: Ideally, induction immunosuppression should be selected in a personalized manner. However, there is little knowledge of what clinical factors are considered in this process…2019 American Transplant Congress
Lymphotoxin Signaling Regulates T Cell Lymphatic Trafficking
*Purpose: Lymphotoxin (LT) α1β2 is crucial for lymphatic organ development and orchestration of immune responses. LTα1β2 is preferentially expressed by regulatory T cells (Treg) for…2019 American Transplant Congress
Results from the LIVE-C Free Trial
*Purpose: Ledipasvir/sofosbuvir (LDV/SOF) in combination with ribavirin (RBV) has shown excellent results post-liver transplant. However, due to the poor tolerability of RBV, it is commonly…
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 214
- Next Page »